Literature DB >> 27131889

Non-coding RNAs as emerging molecular targets of gallbladder cancer.

Dinesh Singh Tekcham1, Pramod Kumar Tiwari2.   

Abstract

Gallbladder cancer is one of the most common cancers of biliary tract with aggressive pathophysiology, now emerging as a global health issue. Although minority of gallbladder cancer patients could receive such curative resection due to late diagnosis, this increases the survival rate. Lack of potential target molecule (s) for early diagnosis, better prognosis and effective therapy of gallbladder cancer has triggered investigators to look for novel technological or high throughput approaches to identify potential biomarker for gallbladder cancer. Intervention of non-coding RNAs in gallbladder cancer has been revealed recently. Non-coding RNAs are now widely implicated in cancer. Recent reports have revealed association of non-coding RNAs (microRNAs or miRNAs and long non-coding RNAs or lncRNAs) with gallbladder cancer. Here, we present an updated overview on the biogenesis, mechanism of action, role of non-coding RNAs, the identified cellular functions in gallbladder tumorigenesis, their prognostic & therapeutic potentials (efficacies) and future significance in developing effective biomarker(s), in future, for gallbladder.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Gallbladder cancer; Long non-coding RNAs; MicroRNA

Mesh:

Substances:

Year:  2016        PMID: 27131889     DOI: 10.1016/j.gene.2016.04.047

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  miR-433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M.

Authors:  Jianhua Yu; Weiguang Zhang; Baochun Lu; Hongwei Qian; Haijun Tang; Zhiyang Zhu; Xinggui Yuan; Peitu Ren
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

Review 2.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

3.  Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.

Authors:  Peng Zhang; Peihua Cao; Xiaofeng Zhu; Mingxin Pan; Kebo Zhong; Rui He; Yang Li; Xingyuan Jiao; Yi Gao
Journal:  Oncotarget       Date:  2017-05-16

4.  Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.

Authors:  Liang Yang; Xi Cheng; Naijian Ge; Weixing Guo; Feiling Feng; Fuying Wan
Journal:  Oncotarget       Date:  2017-01-10

Review 5.  The accuracy of microRNA-210 in diagnosing lung cancer: a systematic review and meta-analysis.

Authors:  Huqin Yang; Huijuan Wang; Chao Zhang; Zhaohui Tong
Journal:  Oncotarget       Date:  2016-09-27

Review 6.  lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis.

Authors:  Wen-Kang Chen; Xiao-Hua Yu; Wei Yang; Cheng Wang; Wen-Si He; Yi-Guo Yan; Jian Zhang; Wen-Jun Wang
Journal:  Cell Prolif       Date:  2016-11-09       Impact factor: 6.831

7.  Antitumor effect of ginsenoside Rg3 on gallbladder cancer by inducing endoplasmic reticulum stress-mediated apoptosis in vitro and in vivo.

Authors:  Keren Wu; Jie Huang; Ning Li; Tao Xu; Wenyu Cai; Zhipeng Ye
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

8.  Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.

Authors:  Guohui Xu; Xiaoyong Wei; Qiang Tu; Cuncai Zhou
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 9.  Gastric cancer: An epigenetic view.

Authors:  Si-Yuan Tang; Pei-Jun Zhou; Yu Meng; Fu-Rong Zeng; Guang-Tong Deng
Journal:  World J Gastrointest Oncol       Date:  2022-01-15

10.  Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.

Authors:  Peizhan Chen; Yueqi Wang; Jingquan Li; Xiaobo Bo; Jie Wang; Lingxi Nan; Changcheng Wang; Qian Ba; Houbao Liu; Hui Wang
Journal:  Clin Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.